TCG Crossover Management, LLC 13F Holdings

CIK 0001839948 · PALO ALTO, CA

As of Sep 30, 2025, TCG Crossover Management, LLC reported 40 positions worth $2.0B in its SEC Form 13F filing.

Top 25 holdings

SecurityTickerSectorSharesValue% of portfolio
ABIVAX SAABVXHealthcare7,111,596$603.8M29.70%
CG ONCOLOGY INCCGONHealthcare3,670,206 47.8M7.27%
COGENT BIOSCIENCES INCCOGTHealthcare6,798,162$97.6M4.80%
AMYLYX PHARMACEUTICALS INCAMLXHealthcare6,243,812$84.9M4.17%
CENTESSA PHARMACEUTICALS PLCCNTAHealthcare3,136,480$76.1M3.74%
TANGO THERAPEUTICS INCTNGXHealthcare8,536,196$71.7M3.53%
OCULAR THERAPEUTIX INCOCULHealthcare6,117,232$71.5M3.52%
DIANTHUS THERAPEUTICS INCDNTHHealthcare1,676,624$66.0M3.25%
TOURMALINE BIO INCTRMLHealthcare1,311,783$62.7M3.09%
DYNE THERAPEUTICS INCDYNHealthcare4,615,144$58.4M2.87%
AGIOS PHARMACEUTICALS INCAGIOHealthcare1,430,041$57.4M2.82%
EYEPOINT PHARMACEUTICALS INCEYPTHealthcare3,572,335$50.9M2.50%
FULCRUM THERAPEUTICS INCFULCHealthcare5,250,000$48.3M2.38%
SAVARA INCSVRAHealthcare12,362,205$44.1M2.17%
RAPT THERAPEUTICS INCRAPTHealthcare1,636,275$42.2M2.08%
TYRA BIOSCIENCES INCTYRAHealthcare2,898,103$40.5M1.99%
UPSTREAM BIO INCUPBHealthcare2,117,103$39.8M1.96%
LIQUIDIA CORPLQDAHealthcare1,710,084$38.9M1.91%
DISC MEDICINE INCIRONHealthcare465,257$30.7M1.51%
STRUCTURE THERAPEUTICS INCGPCRHealthcare1,063,000$29.8M1.46%
XENCOR INCXNCRHealthcare2,452,138$28.8M1.41%
LB PHARMACEUTICALS INCLBRXHealthcare1,745,016$27.6M1.36%
REVOLUTION MEDICINES INCRVMDHealthcare436,473$20.4M1.00%
ASTRIA THERAPEUTICS INCATXSHealthcare2,761,861$20.1M0.99%
KORRO BIO INCKRROHealthcare416,301 9.9M0.98%